This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
Results of an Academic Dialysis Program-Wide SARS-CoV-2 Vaccination Effort
Preprint
in English
| medRxiv
| ID: ppmedrxiv-21256841
ABSTRACT
Patients with End Stage Kidney Disease requiring dialysis are exceedingly vulnerable to SARS-CoV-2 infection with high hospitalization rates and mortality. Despite this risk, little is known about real world dialysis patient SARS-CoV-2 vaccination acceptance. Surveys of the general population suggest significant vaccine hesitancy and high potential for refusal. From January 27th to March 12th 2021, the University of Virginia (UVA) Health System, in partnership with the Virginia Department of Health / Blue Ridge Health District (BRHD) provided on-site mobile vaccination clinics at 12 UVA dialysis sites. We conducted a cross-sectional study to evaluate vaccine acceptance and evaluate factors associated with refusal. Of 859 dialysis patients with complete vaccination data, 80% received at least one dose of vaccine and 87% of these vaccinations were provided by the UVA/BRHD partnership. The overall patient refusal rate was low at 14%. Patients refusing SARS-CoV-2 vaccine were more likely to be female, younger and missing a documented flu vaccination during the 2020-2021 season. Attributes such as race or prior infection with SARS-CoV-2 were not significantly associated with vaccine refusal. In conclusion, dialysis patients in our program were surprisingly likely to accept vaccination for SARS-CoV-2. Identifying attributes associated with refusal may help target populations at high risk of vaccine refusal.
cc_by_nc_nd
Full text:
Available
Collection:
Preprints
Database:
medRxiv
Type of study:
Experimental_studies
/
Observational study
/
Prognostic study
/
Rct
Language:
English
Year:
2021
Document type:
Preprint